C10ORF12 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.76365605347928E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.36568534259141E-12 |
Normal-vs-Stage2 |
2.3057999953835E-10 |
Normal-vs-Stage3 |
6.66133814775094E-16 |
Normal-vs-Stage4 |
1.77047265736974E-12 |
Stage1-vs-Stage2 |
6.023800E-01 |
Stage1-vs-Stage3 |
8.219900E-03 |
Stage1-vs-Stage4 |
2.024800E-01 |
Stage2-vs-Stage3 |
1.656180E-01 |
Stage2-vs-Stage4 |
6.178000E-01 |
Stage3-vs-Stage4 |
3.613600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.69042557729426E-12 |
Normal-vs-AfricanAmerican |
6.00997029920336E-12 |
Normal-vs-Asian |
4.900500E-02 |
Caucasian-vs-AfricanAmerican |
1.542960E-01 |
Caucasian-vs-Asian |
2.058000E-01 |
AfricanAmerican-vs-Asian |
1.175430E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.58681964737661E-14 |
Normal-vs-Female |
3.20965476419133E-13 |
Male-vs-Female |
4.762400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.3019000000033E-06 |
Normal-vs-Age(41-60Yrs) |
3.81361608958741E-12 |
Normal-vs-Age(61-80Yrs) |
6.66133814775094E-15 |
Normal-vs-Age(81-100Yrs) |
4.96380714309907E-13 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.116400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.193600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.101190E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.431500E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.176500E-03 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.208030E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
9.076500E-03 |
Normal-vs-Grade 2 |
2.99982261253717E-13 |
Normal-vs-Grade 3 |
2.35367281220533E-14 |
Normal-vs-Grade 4 |
1.89626092605977E-12 |
Grade 1-vs-Grade 2 |
1.455390E-01 |
Grade 1-vs-Grade 3 |
7.808300E-02 |
Grade 1-vs-Grade 4 |
7.045900E-02 |
Grade 2-vs-Grade 3 |
3.528600E-01 |
Grade 2-vs-Grade 4 |
2.723600E-01 |
Grade 3-vs-Grade 4 |
6.738600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.02344824124157E-12 |
Normal-vs-ccB subtype |
1.63369318073592E-12 |
ccA subtype-vs-ccB subtype |
8.611400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
6.11621864265999E-13 |
Normal-vs-N1 |
1.019890E-03 |
N0-vs-N1 |
6.269600E-01 |
|
|